The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
- Home |
- FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board
FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board
- April 28, 2026
Recent Posts
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
- Cenovus to build oil sands business via Athabasca acquisition
- Centalion acquires Haynesville gas assets from Silver Hill
